Propel
Device Otolaryngology (Ear, Nose, Throat)
General payments
$912,101
Research payments
$297,881
Through program year 2021, $912,101 in general payments and $297,881 in research payments were reported against Propel (Otolaryngology (Ear, Nose, Throat)).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $279,814 | 2,468 |
| 2021 | Research | $297,881 | 44 |
| 2020 | General | $95,074 | 1,644 |
| 2019 | General | $537,213 | 5,266 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
9,378 general · 44 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.